BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 8230863)

  • 1. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
    Yamaguchi T; Aihara K; Yamada S; Narita S; Kogi K
    Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
    Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
    J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of YJA20379-4 on gastric secretion, Helicobacter pylori growth and various gastric and duodenal lesions in rats.
    Woo TW; Chang MS; Chung YK; Kim KB; Sohn SK; Kim SG; Choi WS
    Biol Pharm Bull; 1998 May; 21(5):449-55. PubMed ID: 9635498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and pharmacological properties of a new proton pump inhibitor, 2-amino-4,5-dihydropyrido[1,2-a]thiazolo [5,4-g] benzimidazole (YJA20379-5).
    Sohn SK; Chang MS; Chung YK; Kim KB; Wook TW; Kim SG; Choi WS
    Arch Pharm Res; 1998 Jun; 21(3):241-7. PubMed ID: 9875438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biochemical and pharmacological properties of a newly synthesized H+-K+ ATPase inhibitor, 2-dimethylamino-4,5-dihydrothiazolo[4,5:3,4]pyridol-[1,2-a]benzimidazol e.
    Chung YK; Chang MS; Kim KB; Sohn SK; Woo TW; Lee SB; Choi WS
    Can J Physiol Pharmacol; 1998 Sep; 76(9):921-9. PubMed ID: 10066143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and pharmacological characteristics of a newly synthesized H+/K+-ATPase inhibitor, YJA20379-8, 3-butyryl-4-[R-1-methylbenzylamino]-8-ethoxy-1,7-naphthyridine, in pigs and rats.
    Sohn SK; Chang MS; Choi WS; Chung YK; Kim KB; Woo TW; Lee SB; Park CJ
    J Pharm Pharmacol; 1999 Dec; 51(12):1359-65. PubMed ID: 10678489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a new benzimidazole derivative, NC-1300-O-3, on gastric secretion and gastroduodenal lesions in rats.
    Okabe S; Akimoto Y; Yamasaki S; Kuwahara K
    Jpn J Pharmacol; 1991 Apr; 55(4):477-91. PubMed ID: 1832198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and pharmacological analysis of 2-[(2-dimethylaminobenzyl)sulfinyl] benzimidazole (NC-1300), a new proton pump inhibitor.
    Okabe S; Higaki E; Higuchi T; Sato M; Hara K
    Jpn J Pharmacol; 1986 Feb; 40(2):239-49. PubMed ID: 3009944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
    Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
    J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiulcer activities of novel 2-[(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)sulfinyl]-1H- benzimidazole analogues.
    Yamada S; Goto T; Shimanuki E; Narita S
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):718-20. PubMed ID: 8004722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats.
    Kinoshita M; Saito N; Tamaki H
    Eur J Pharmacol; 1997 Mar; 321(3):325-32. PubMed ID: 9085044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats.
    Yamamoto O; Okada Y; Okabe S
    Dig Dis Sci; 1984 May; 29(5):394-401. PubMed ID: 6714055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and pharmacological characteristics of a newly synthesized H+-K+ ATPase inhibitor, YJA20379-1, 2-amino-4,5-dihydro-8-phenylimidazole[2,1-b]thiazolo[5,4-g]benzothiazol e.
    Sohn SK; Chang MS; Choi WS; Kim KB; Woo TW; Lee SB; Chung YK
    Can J Physiol Pharmacol; 1999 May; 77(5):330-8. PubMed ID: 10535682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric antisecretory and anti-ulcer effect of ME3407, a new benzimidazole derivative, in rats.
    Tanaka J; Iida H; Abe M; Yuda Y; Inoue S; Okabe S
    Arzneimittelforschung; 2004; 54(4):221-9. PubMed ID: 15146935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
    Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
    J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole.
    Takeuchi K; Konaka A; Nishijima M; Kato S; Yasuhiro T
    J Gastroenterol Hepatol; 1999 Mar; 14(3):251-7. PubMed ID: 10197495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion and gastroduodenal ulcers in rats.
    Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
    Methods Find Exp Clin Pharmacol; 1999 Mar; 21(2):115-22. PubMed ID: 10327392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K; Kato S; Yamamoto H; Okabe S
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.